RT Journal Article
SR Electronic
T1 Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin’s lymphoma: a phase II, non-randomized controlled trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004445
DO 10.1136/jitc-2021-004445
VO 10
IS 5
A1 Hochberg, Jessica
A1 Basso, Jaclyn
A1 Shi, Qiuhu
A1 Klejmont, Liana
A1 Flower, Allyson
A1 Bortfeld, Kristina
A1 Harrison, Lauren
A1 van de Ven, Carmella
A1 Moorthy, Chitti
A1 Islam, Humayun
A1 Gerard, Perry
A1 Voss, Stephan
A1 Cairo, Mitchell S
YR 2022
UL http://jitc.bmj.com/content/10/5/e004445.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.